For the quarter ending 2025-12-31, YCBD made $5,016,904 in revenue. -$324,602 in net income. Net profit margin of -6.47%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Total net sales | 5,016,904 | 4,720,770 | 4,606,796 | 4,749,426 |
| Cost of sales | 2,015,610 | 1,943,575 | 1,775,709 | 1,790,062 |
| Gross profit | 3,001,294 | 2,777,195 | 2,831,087 | 2,959,364 |
| Operating expenses | 3,287,582 | 3,463,011 | 3,735,773 | 3,445,180 |
| Loss from operations | -286,288 | -685,816 | -904,686 | -485,816 |
| Decrease of contingent liability | - | 0 | 0 | - |
| Decrease in fair value of convertible debt | 0 | 0 | 0 | -2,583 |
| Interest income | 3,157 | 5,848 | 9,414 | 7,642 |
| (loss) income before provision for income taxes | -283,131 | -679,968 | -895,272 | -480,757 |
| Benefit (expense) for income taxes | - | 0 | - | - |
| Net (loss) income | -283,131 | -679,968 | -895,272 | -480,757 |
| Preferred dividends | 41,471 | 0 | 333,500 | 1,000,500 |
| Net loss attributable to cbdmd, inc. common shareholders | -324,602 | -679,968 | -1,228,772 | -1,481,257 |
| Us-gaap_earningspersharediluted | - | -0.273 | - | - |
| Us-gaap_weightedaveragenumberofdilutedsharesoutstanding | - | 1,005,657.25 | - | - |
| Basic and diluted loss per share (in dollars per share) | -0.04 | 1.24 | -0.21 | -1.9 |
| Weighted average number of shares basic and diluted (in shares) | 9,003,951 | -7,091,202 | 5,783,354 | 778,410 |
cbdMD, Inc. (YCBD)
cbdMD, Inc. (YCBD)